OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of berberine in Covid-19: potential adjunct therapy
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 31
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
Chong Qiu, Jun Zhe Zhang, Bo Wu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Chong Qiu, Jun Zhe Zhang, Bo Wu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sarah Albogami, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1361-1361
Open Access | Times Cited: 22
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sarah Albogami, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1361-1361
Open Access | Times Cited: 22
Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 15
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 15
The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
Raed AlRuwaili, Hayder M. Al‐kuraishy, Mubarak Alruwaili, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1267-1278
Open Access | Times Cited: 15
Raed AlRuwaili, Hayder M. Al‐kuraishy, Mubarak Alruwaili, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1267-1278
Open Access | Times Cited: 15
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions
Isaac Baidoo, Paromita Sarbadhikary, Heidi Abrahamse, et al.
Nanomedicine (2025), pp. 1-18
Open Access
Isaac Baidoo, Paromita Sarbadhikary, Heidi Abrahamse, et al.
Nanomedicine (2025), pp. 1-18
Open Access
Dantrolene and ryanodine receptors in COVID ‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Therapeutic Application of Berberine: a Consolidated Review
Techi Mana, Oinam Bidyalaxmi Devi, Yengkhom Disco Singh
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 329-340
Closed Access | Times Cited: 11
Techi Mana, Oinam Bidyalaxmi Devi, Yengkhom Disco Singh
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 329-340
Closed Access | Times Cited: 11
The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective
Bshra A. Alsfouk, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111189-111189
Open Access
Bshra A. Alsfouk, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111189-111189
Open Access
Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil
Saad Misfer Alqahtani, Hayder M. Al-Kuraishy, Ali I. Al‐Gareeb, et al.
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access
Saad Misfer Alqahtani, Hayder M. Al-Kuraishy, Ali I. Al‐Gareeb, et al.
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access
Berberine hydrochloride ameliorates PM2.5-induced pulmonary fibrosis in mice through inhibiting oxidative stress and inflammatory
Jiali Zhao, Xuan Ma, Siqi Li, et al.
Chemico-Biological Interactions (2023) Vol. 386, pp. 110731-110731
Closed Access | Times Cited: 10
Jiali Zhao, Xuan Ma, Siqi Li, et al.
Chemico-Biological Interactions (2023) Vol. 386, pp. 110731-110731
Closed Access | Times Cited: 10
Bile acids and bile acid activated receptors in the treatment of Covid-19
Stefano Fiorucci, Ginevra Urbani, Michele Biagioli, et al.
Biochemical Pharmacology (2023) Vol. 228, pp. 115983-115983
Open Access | Times Cited: 10
Stefano Fiorucci, Ginevra Urbani, Michele Biagioli, et al.
Biochemical Pharmacology (2023) Vol. 228, pp. 115983-115983
Open Access | Times Cited: 10
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Bile acids and coronavirus disease 2019
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Xiaoru Huang, Xuening Liu, Zijian Li
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1939-1950
Open Access | Times Cited: 3
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 8
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 8
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017–2023)
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, et al.
ACS Pharmacology & Translational Science (2023) Vol. 7, Iss. 1, pp. 48-71
Closed Access | Times Cited: 7
Mehdi Valipour, Zahra Zakeri Khatir, Elaheh Abdollahi, et al.
ACS Pharmacology & Translational Science (2023) Vol. 7, Iss. 1, pp. 48-71
Closed Access | Times Cited: 7
Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways
Anish Maskey, Daniel Kopulos, Matthew D. Kwan, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1639-1639
Open Access | Times Cited: 2
Anish Maskey, Daniel Kopulos, Matthew D. Kwan, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1639-1639
Open Access | Times Cited: 2
Possible role of LCZ696 in atherosclerosis: new inroads and perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1895-1908
Closed Access | Times Cited: 6
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1895-1908
Closed Access | Times Cited: 6
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 10
Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
Divya Sharma, Neetika Sharma, Namish Manchanda, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 10
Divya Sharma, Neetika Sharma, Namish Manchanda, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 10
Plausibility of natural immunomodulators in the treatment of COVID-19–A comprehensive analysis and future recommendations
Raushanara Akter, Md. Rashidur Rahman, Zainab Ahmed, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17478-e17478
Open Access | Times Cited: 5
Raushanara Akter, Md. Rashidur Rahman, Zainab Ahmed, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17478-e17478
Open Access | Times Cited: 5
A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study
A. S. Aruna, K. R. Remesh Babu, K. Deepthi
Molecular Diversity (2024)
Closed Access | Times Cited: 1
A. S. Aruna, K. R. Remesh Babu, K. Deepthi
Molecular Diversity (2024)
Closed Access | Times Cited: 1
AMP kinase: A promising therapeutic drug target for post-COVID-19 complications
Mohammad Saquib Ashraf, Kanika Tuli, Shadman Moiz, et al.
Life Sciences (2024) Vol. 359, pp. 123202-123202
Closed Access | Times Cited: 1
Mohammad Saquib Ashraf, Kanika Tuli, Shadman Moiz, et al.
Life Sciences (2024) Vol. 359, pp. 123202-123202
Closed Access | Times Cited: 1
Investigation of Antioxidant and Anti-inflammatory Properties of Berberine Nanomicelles: In vitro and In vivo Studies
Marjan Heidarzadeh, Mehriar Amininasab, Seyed Mahdi Rezayat, et al.
Current Drug Delivery (2023) Vol. 21, Iss. 9, pp. 1273-1283
Closed Access | Times Cited: 2
Marjan Heidarzadeh, Mehriar Amininasab, Seyed Mahdi Rezayat, et al.
Current Drug Delivery (2023) Vol. 21, Iss. 9, pp. 1273-1283
Closed Access | Times Cited: 2
